Enclomiphene citrate: A treatment that maintains fertility in men with secondary hypogonadism

References

• Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.
   PubMed Web of Science ®Google Scholar
• Veldhuis JD, Carlson ML, Johnson ML. The pituitary secrets in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA. 1987;84:7686–7690.
   PubMed Web of Science ®Google Scholar
• Tobin VA, Canny BJ. The regulation of gonadotropin-releasing hormone- induced calcium signals in male rat gonadotrophs by testosterone is mediated by dihydrotestosterone. Endocrinology. 1998;139:1038–1045.
   PubMed Web of Science ®Google Scholar
• Kawakami S, Winters SJ. Regulation of lutenizing hormone secretion and subunit messenger ribonucleic acid expression by gonadal steroids in perifused pituitary cells from male monkeys and rats. Endocrinology. 1999;140:3587–3593.
   PubMed Web of Science ®Google Scholar
• Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2008;60(7):762–769.
   Web of Science ®Google Scholar
• Wu FC, Tajar A, Pye SR, et al. The European male aging study group; hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the european male aging study. J Clin Endocrinol Metab. 2008;93(7):2737–2745.
   PubMed Web of Science ®Google Scholar
• Araujo AB, Esche GR, Kupelian V, et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241–4247.
   PubMed Web of Science ®Google Scholar
• Bandari J, Ayyash OM, Emery SL, et al. Marketing and Testosterone Treatment in the USA: A Systematic Review. Eur Urol Focus. 2017;3(4–5):395–402.
   PubMedGoogle Scholar
• Repros Therpeutics Inc. Advisory committee industry briefing document. Bone, Reproductive, and Urologic Drugs Advisory Committee. 2015;1-161
   Google Scholar
• Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374:611–624.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons from the testosterone trials. Endocr Rev. 2018;39(3):369–386.
   PubMed Web of Science ®Google Scholar
• Kim ED, Crosnoe L, Bar-Chama N, et al. The treatment of hypogonadism in men of reproductive age. Fertil Steril. 2013;99:718–724.
   PubMedGoogle Scholar
• WHO Task Force. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 1990;336:955–959.
   PubMed Web of Science ®Google Scholar
• Pastuszak AW, Gomez JP, Scovell JM, et al. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015;3(3):165–173.
   PubMed Web of Science ®Google Scholar
• Coss CC, Jones A, Hancock ML, et al. Selective androgen receptor modulators for the treatment of late onset male hypogonadism. Asian J Androl. 2014;16(2):256–261.
   PubMed Web of Science ®Google Scholar
• La Vignera S, Condorelli RA, Cimino L, et al. Late-onset hypogonadism: the advantages of treatment with human chorionic gonadotropin rather than testosterone. Aging Male. 2018;19(1):34–39.
   Web of Science ®Google Scholar
• Hoffman AR, Crowley WF. Jr Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N Engl J Med. 1982;307:1237–1241.
   PubMed Web of Science ®Google Scholar
• Pitteloud N, Dwyer AA, DeCruz S, et al. Ihibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 2008;93:784–791.
   PubMed Web of Science ®Google Scholar
• Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. 2016;117:677–685.
   PubMed Web of Science ®Google Scholar
• Huang ES, Miller WL. Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture. Endocrinology. 1983;112(2):442–448.
   PubMed Web of Science ®Google Scholar
• Fontenot GK, Wiehle RD, Podolski JS. Differential effects of isomers of clomiphene citrate on reproductive tissues in male mice. BJU Int. 2016;17(2):344–350.
   Google Scholar
• Kurosawa T, Hiroi H, Momoeda M, et al. Clomiphene citrate elicits estrogen agonistic/antagonistic effects differentially via estrogen receptors alpha and beta. Endocr J. 2010;57(6):517–521.
   PubMed Web of Science ®Google Scholar
• Rodriguez KM, Pastuszak AW, Lipshultz LI. Enclomiphene citrate for the treatment of secondary male hypogonadism. Expert Opin Pharmoacother. 2016;17(11):1561–1567.
   PubMed Web of Science ®Google Scholar
• Wiehle R, Cunningham GR, Pitteloud N, et al. Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study. BJU Int. 2013;112:1188–1200.
   Web of Science ®Google Scholar
• Wiehle RD, Fontenot GK, Willet MS, et al. Enclomiphene citrate stimulates serum testosterone in men with low testosterone within 14 days. Journal of Men‘s Health. 2014;11(4):196–205.
   Web of Science ®Google Scholar
• Mikkelson TJ, Kroboth PD, Cameron WJ, et al. Single dose pharamacokinetics of clomiphene citrate in normal volunteers. Fertil Steril. 1986;46:392–396.
   PubMed Web of Science ®Google Scholar
• Kaminetsky J, Werner M, Fontenot G, et al. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med. 2013;10(6):1628–1635.
   PubMed Web of Science ®Google Scholar
• Wiehle RD, Tobler KJ, Omurtag KR, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertil Steril. 2014;102(3):720–727.
   PubMed Web of Science ®Google Scholar
• CLOMID® (clomiphene citrate tablets USP). cited 14 May, 2018. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/016131s026lbl.pdf
   Google Scholar
• Moskovic DJ, Katz DJ, Akhavan A, et al. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int. 2014;110:1524–1528.
   Web of Science ®Google Scholar